Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2021) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Dates:
  • Published: April 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 13 Oct 2021 15:22
Last Modified: 13 Oct 2021 15:22
Status: Published
Identification Number: 10.1093/rheumatology/keab247.169
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)